Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma

por Song, Fei, Hu, Bo, Cheng, Jian-Wen, Sun, Yun-Fan, Zhou, Kai-Qian, Wang, Peng-Xiang, Guo, Wei, Zhou, Jian, Fan, Jia, Chen, Zhong, Yang, Xin-Rong
Publicado 2020

Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine

por Gao, Yang, Zhou, Rong, Huang, Jun-Feng, Hu, Bo, Cheng, Jian-Wen, Huang, Xiao-Wu, Wang, Peng-Xiang, Peng, Hai-Xiang, Guo, Wei, Zhou, Jian, Fan, Jia, Yang, Xin-Rong
Publicado 2021

CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5‐LSD1‐NF‐κB oncogenic signaling

por Hu, Bo, Xu, Yang, Li, Yuan‐Cheng, Huang, Jun‐Feng, Cheng, Jian‐Wen, Guo, Wei, Yin, Yue, Gao, Yang, Wang, Peng‐Xiang, Wu, Sui‐Yi, Zhou, Jian, Fan, Jia, Yang, Xin‐Rong
Publicado 2020

Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐...

por Wang, Peng‐Xiang, Sun, Yun‐Fan, Zhou, Kai‐Qian, Cheng, Jian‐Wen, Hu, Bo, Guo, Wei, Yin, Yue, Huang, Jun‐Feng, Zhou, Jian, Fan, Jia, Cheung, Tan To, Qu, Xu‐Dong, Yang, Xin‐Rong
Publicado 2020

Mucin 1 promotes tumor progression through activating WNT/β-catenin signaling pathway in intrahepatic cholangiocarcinoma

por Song, Fei, Chen, Fei-Yu, Wu, Sui-Yi, Hu, Bo, Liang, Xiao-liang, Yang, Hao-Qin, Cheng, Jian-Wen, Wang, Peng-Xiang, Guo, Wei, Zhou, Jian, Fan, Jia, Chen, Zhong, Yang, Xin-Rong
Publicado 2021

Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma

por Zhou, Kai-Qian, Sun, Yun-Fan, Cheng, Jian-Wen, Du, Min, Ji, Yuan, Wang, Peng-Xiang, Hu, Bo, Guo, Wei, Gao, Yang, Yin, Yue, Huang, Jun-Feng, Zhou, Jian, Fan, Jia, Yang, Xin-Rong
Publicado 2020

Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival ana...

por Gao, Yang, Wang, Peng‐Xiang, Cheng, Jian‐Wen, Sun, Yun‐Fan, Hu, Bo, Guo, Wei, Zhou, Kai‐Qian, Yin, Yue, Li, Yuan‐Cheng, Wang, Jian, Huang, Jun‐Feng, Qiu, Shuang‐Jian, Zhou, Jian, Fan, Jia, Yang, Xin‐Rong
Publicado 2019

BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity

por Yang, Wen-Jing, Sun, Yun-Fan, Jin, An-Li, Lv, Li-Hua, Zhu, Jie, Wang, Bei-Li, Zhou, Yan, Zhang, Chun-Yan, Wang, Hao, Hu, Bo, Wang, Peng-Xiang, Te, Liu, Pan, Bai-Shen, Zhou, Jian, Fan, Jia, Yang, Xin-Rong, Guo, Wei
Publicado 2020

Circulating tumor cell detection and single‐cell analysis using an integrated workflow based on ChimeraX(®)‐i120 Platform: A prospective study

por Wang, Peng‐Xiang, Sun, Yun‐Fan, Jin, Wei‐Xiang, Cheng, Jian‐Wen, Peng, Hai‐Xiang, Xu, Yang, Zhou, Kai‐Qian, Chen, Li‐Meng, Huang, Kai, Wu, Sui‐Yi, Hu, Bo, Zhang, Ze‐Fan, Guo, Wei, Cao, Ya, Zhou, Jian, Fan, Jia, Yang, Xin‐Rong
Publicado 2020

CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis

por Jin, An‐Li, Zhang, Chun‐Yan, Zheng, Wen‐Jing, Xian, Jing‐Rong, Yang, Wen‐Jing, Liu, Te, Chen, Wei, Li, Tong, Wang, Bei‐Li, Pan, Bai‐Shen, Li, Qian, Cheng, Jian‐Wen, Wang, Peng‐Xiang, Hu, Bo, Zhou, Jian, Fan, Jia, Yang, Xin‐Rong, Guo, Wei
Publicado 2022